These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17617743)
1. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Ali SS; Chandrashekar SR; Singh M; Bansal RK; Sharma DR; Arora D Hum Vaccin; 2007; 3(4):116-20. PubMed ID: 17617743 [TBL] [Abstract][Full Text] [Related]
2. A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP-HepB-Hib vaccine in indian infants. Eregowda A; Lalwani S; Chatterjee S; Vakil H; Ahmed K; Costantini M; Lattanzi M Hum Vaccin Immunother; 2013 Sep; 9(9):1903-9. PubMed ID: 23783081 [TBL] [Abstract][Full Text] [Related]
3. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age. Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine. Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa. Vesikari T; Rivera L; Korhonen T; Ahonen A; Cheuvart B; Hezareh M; Janssens W; Mesaros N Hum Vaccin Immunother; 2017 Jul; 13(7):1505-1515. PubMed ID: 28340322 [TBL] [Abstract][Full Text] [Related]
6. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine. Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088 [TBL] [Abstract][Full Text] [Related]
8. Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants. Gandhi DJ; Dhaded SM; Ravi MD; Dubey AP; Kundu R; Lalwani SK; Chhatwal J; Mathew LG; Gupta M; Sharma SD; Bavdekar SB; Jayanth MV; Ravinuthala S; Sil A; Dhingra MS Hum Vaccin Immunother; 2016 Apr; 12(4):946-54. PubMed ID: 26580093 [TBL] [Abstract][Full Text] [Related]
9. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435 [TBL] [Abstract][Full Text] [Related]
10. A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine. Dalvi S; Kulkarni PS; Phadke MA; More SS; Lalwani SK; Jain D; Manglani M; Garg BS; Doibale MK; Deshmukh CT; Hum Vaccin Immunother; 2015; 11(4):901-7. PubMed ID: 25933183 [TBL] [Abstract][Full Text] [Related]
11. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [TBL] [Abstract][Full Text] [Related]
12. Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants. Sil A; Ravi MD; Patnaik BN; Dhingra MS; Dupuy M; Gandhi DJ; Dhaded SM; Dubey AP; Kundu R; Lalwani SK; Chhatwal J; Mathew LG; Gupta M; Sharma SD; Bavdekar SB; Rout SP; Jayanth MV; D'Cor NA; Mangarule SA; Ravinuthala S; Reddy E J Vaccine; 2017 May; 35(22):2999-3006. PubMed ID: 28449972 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children. Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177 [TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Kanra G; Kara A; Demiralp O; Contorni M; Hilbert AK; Spyr C; Viviani S Hum Vaccin; 2006; 2(4):155-60. PubMed ID: 17012890 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study. Capeding MR; Alberto E; Versteilen A; Rauscher M; Bagchi P; Palacios PI Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083 [TBL] [Abstract][Full Text] [Related]
16. A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants. Mohanty L; Sharma S; Behera B; Panwar S; Paliwal C; Gupta A; Chilkoti DC; Singh A Vaccine; 2018 Apr; 36(17):2378-2384. PubMed ID: 29580640 [TBL] [Abstract][Full Text] [Related]
17. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE. Huu TN; Phuong NT; Toan NT; Thang HV Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396 [TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age. Szenborn L; Czajka H; Brzostek J; Konior R; Caubet M; Ulianov L; Leyssen M Pediatr Infect Dis J; 2013 Jul; 32(7):777-85. PubMed ID: 23838777 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine. Gentile A; Umido V; Czerniuk P; Nacul J; Seigelchifer M; Hilbert AK; Yela U; Herzog C; Aeberhard U; Spyr C Int J Infect Dis; 2011 Jan; 15(1):e24-9. PubMed ID: 21093342 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety in infants of a DTwPHib full liquid vaccine. Botet Asensi FI; Veronese A; Del Carmen Otero M; Desamparados Tamarit Pérez M; Hontangas Lopez JL; Viviani S Acta Paediatr; 2003 May; 92(5):541-5. PubMed ID: 12839281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]